Tonix Pharmaceuticals Holding has reported preliminary positive results after vaccination of non-human primates with TNX-1800, a live modified horsepox virus vaccine for percutaneous administration that is designed to express the Spike protein of ...
Tonix Pharmaceuticals has expanded its ongoing partnership with non-profit Southern Research to study T-cell immune responses to SARS-CoV-2, the novel coronavirus that causes Covid-19.